Storia in 2 fonti

Roche details narrow failure of breast cancer pill trial

Back in March, Roche revealed that its breast cancer pill had failed in a pivotal Phase 3 trial. Data presented at ASCO reveal why.

Raccontata da

endpoints.news

fiercebiotech.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo11 h fa

Roche details narrow failure of breast cancer pill trial

Back in March, Roche revealed that its breast cancer pill had failed in a pivotal Phase 3 trial. Data presented at ASCO reveal why.

originale

fiercebiotech.com6 h fa

ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer

To Roche, a phase 3 flop in first-line breast cancer does not erase the megablockbuster potential of its oral SERD drug giredestrant even as competition mounts. | To Roche, a phase 3 flop in first-line breast cancer…

Leggi questa versione → originale

Timeline cronologica

martedì 2 giugno 2026·endpoints.news
Roche details narrow failure of breast cancer pill trial
Back in March, Roche revealed that its breast cancer pill had failed in a pivotal Phase 3 trial. Data presented at ASCO reveal why.
martedì 2 giugno 2026·fiercebiotech.com
ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer
To Roche, a phase 3 flop in first-line breast cancer does not erase the megablockbuster potential of its oral SERD drug giredestrant even as competition mounts. | To Roche, a…